Form 4: Ironwood Pharmaceuticals' Chief Legal Officer Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
John Minardo, Chief Legal Officer of Ironwood Pharmaceuticals, sold shares to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On February 10, 2025, John Minardo, the Chief Legal Officer of Ironwood Pharmaceuticals, engaged in transactions involving Class A Common Stock.
- He acquired 447,070 shares and disposed of 38,938 shares at a price of $1.76 per share.
- The sale was to cover tax withholding obligations related to the vesting of restricted stock units and performance-based restricted stock units.
- Following these transactions, Minardo beneficially owns 408,132 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: Neutral sentiment as the filing relates to routine stock transactions for tax purposes.
Industry Context
This is a routine transaction related to executive compensation and tax obligations, common in publicly traded companies.
Stakeholder Impact
- The sale of shares by an officer could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 2025-02-07 | Date of Power of Attorney execution. |
| 2025-02-10 | Date of the stock transactions (acquisition and sale). |
| 2025-02-12 | Date of signature for the SEC filing. |
Keywords
Ironwood Pharmaceuticals, John Minardo, Class A Common Stock, SEC Form 4, Share Sale, Restricted Stock Units, Tax Withholding, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.